Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1α/VEGF signaling pathways in human breast cancer cells

Xudong Tang, Qunzhou Zhang, Shihong Shi, Yun Yen, Xiangyong Li, Yuefei Zhang, Keyuan Zhou, Anh D. Le

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, in vitro and in vivo, via several mechanisms, including antiangiogenesis. In this study, we investigated the potential molecular mechanisms underlying the antiangiogenic effect of non-nitrogen-containing and nitrogen-containing bisphosphonates, clodronate and pamidronate, respectively, in insulin-like growth factor (IGF)-1 responsive human breast cancer cells. We tested whether bisphosphonates had any effects on hypoxia-inducible factor (HIF)-1α/vascular endothelial growth factor (VEGF) axis that plays a pivotal role in tumor angiogenesis, and our results showed that both pamidronate and clodronate significantly suppressed IGF-1-induced HIF-1α protein accumulation and VEGF expression in MCF-7 cells. Mechanistically, we found that either pamidronate or clodronate did not affect mRNA expression of HIF-1α, but they apparently promoted the degradation of IGF-1-induced HIF-1α protein. Meanwhile, we found that the presence of pamidronate and clodronate led to a dose-dependent decease in the newly-synthesized HIF-1α protein induced by IGF-1 in breast cancer cells after proteasomal inhibition, thus, indirectly reflecting the inhibition of protein synthesis. In addition, our results indicated that the inhibitory effects of bisphosphonates on the HIF-1α/VEGF axis are associated with the inhibition of the phosphoinositide 3-kinase/AKT/ mammalian target of rapamycin signaling pathways. Consistently, we demonstrated that pamidronate and clodronate functionally abrogated both in vitro and in vivo tumor angiogenesis induced by IGF-1-stimulated MCF-7 cells. These findings have highlighted an important mechanism of the pharmacological action of bisphosphonates in the inhibition of tumor angiogenesis in breast cancer cells.

Original languageEnglish
Pages (from-to)90-103
Number of pages14
JournalInternational Journal of Cancer
Volume126
Issue number1
DOIs
Publication statusPublished - Jan 1 2010
Externally publishedYes

Fingerprint

pamidronate
Hypoxia-Inducible Factor 1
Clodronic Acid
Diphosphonates
Somatomedins
Vascular Endothelial Growth Factor A
Breast Neoplasms
MCF-7 Cells
Proteins
Molecular Mechanisms of Pharmacological Action
Neoplasms
1-Phosphatidylinositol 4-Kinase
Sirolimus
Nitrogen
Neoplasm Metastasis
Bone and Bones
Drug Therapy
Messenger RNA

Keywords

  • Angiogenesis
  • Bisphosphonates
  • Breast cancer
  • HIF-1α
  • IGF-1
  • PI-3K/Akt
  • VEGF

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1α/VEGF signaling pathways in human breast cancer cells. / Tang, Xudong; Zhang, Qunzhou; Shi, Shihong; Yen, Yun; Li, Xiangyong; Zhang, Yuefei; Zhou, Keyuan; Le, Anh D.

In: International Journal of Cancer, Vol. 126, No. 1, 01.01.2010, p. 90-103.

Research output: Contribution to journalArticle

Tang, Xudong ; Zhang, Qunzhou ; Shi, Shihong ; Yen, Yun ; Li, Xiangyong ; Zhang, Yuefei ; Zhou, Keyuan ; Le, Anh D. / Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1α/VEGF signaling pathways in human breast cancer cells. In: International Journal of Cancer. 2010 ; Vol. 126, No. 1. pp. 90-103.
@article{c261c540cc8e48d38d7cae3680c92728,
title = "Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1α/VEGF signaling pathways in human breast cancer cells",
abstract = "Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, in vitro and in vivo, via several mechanisms, including antiangiogenesis. In this study, we investigated the potential molecular mechanisms underlying the antiangiogenic effect of non-nitrogen-containing and nitrogen-containing bisphosphonates, clodronate and pamidronate, respectively, in insulin-like growth factor (IGF)-1 responsive human breast cancer cells. We tested whether bisphosphonates had any effects on hypoxia-inducible factor (HIF)-1α/vascular endothelial growth factor (VEGF) axis that plays a pivotal role in tumor angiogenesis, and our results showed that both pamidronate and clodronate significantly suppressed IGF-1-induced HIF-1α protein accumulation and VEGF expression in MCF-7 cells. Mechanistically, we found that either pamidronate or clodronate did not affect mRNA expression of HIF-1α, but they apparently promoted the degradation of IGF-1-induced HIF-1α protein. Meanwhile, we found that the presence of pamidronate and clodronate led to a dose-dependent decease in the newly-synthesized HIF-1α protein induced by IGF-1 in breast cancer cells after proteasomal inhibition, thus, indirectly reflecting the inhibition of protein synthesis. In addition, our results indicated that the inhibitory effects of bisphosphonates on the HIF-1α/VEGF axis are associated with the inhibition of the phosphoinositide 3-kinase/AKT/ mammalian target of rapamycin signaling pathways. Consistently, we demonstrated that pamidronate and clodronate functionally abrogated both in vitro and in vivo tumor angiogenesis induced by IGF-1-stimulated MCF-7 cells. These findings have highlighted an important mechanism of the pharmacological action of bisphosphonates in the inhibition of tumor angiogenesis in breast cancer cells.",
keywords = "Angiogenesis, Bisphosphonates, Breast cancer, HIF-1α, IGF-1, PI-3K/Akt, VEGF",
author = "Xudong Tang and Qunzhou Zhang and Shihong Shi and Yun Yen and Xiangyong Li and Yuefei Zhang and Keyuan Zhou and Le, {Anh D.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/ijc.24710",
language = "English",
volume = "126",
pages = "90--103",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1α/VEGF signaling pathways in human breast cancer cells

AU - Tang, Xudong

AU - Zhang, Qunzhou

AU - Shi, Shihong

AU - Yen, Yun

AU - Li, Xiangyong

AU - Zhang, Yuefei

AU - Zhou, Keyuan

AU - Le, Anh D.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, in vitro and in vivo, via several mechanisms, including antiangiogenesis. In this study, we investigated the potential molecular mechanisms underlying the antiangiogenic effect of non-nitrogen-containing and nitrogen-containing bisphosphonates, clodronate and pamidronate, respectively, in insulin-like growth factor (IGF)-1 responsive human breast cancer cells. We tested whether bisphosphonates had any effects on hypoxia-inducible factor (HIF)-1α/vascular endothelial growth factor (VEGF) axis that plays a pivotal role in tumor angiogenesis, and our results showed that both pamidronate and clodronate significantly suppressed IGF-1-induced HIF-1α protein accumulation and VEGF expression in MCF-7 cells. Mechanistically, we found that either pamidronate or clodronate did not affect mRNA expression of HIF-1α, but they apparently promoted the degradation of IGF-1-induced HIF-1α protein. Meanwhile, we found that the presence of pamidronate and clodronate led to a dose-dependent decease in the newly-synthesized HIF-1α protein induced by IGF-1 in breast cancer cells after proteasomal inhibition, thus, indirectly reflecting the inhibition of protein synthesis. In addition, our results indicated that the inhibitory effects of bisphosphonates on the HIF-1α/VEGF axis are associated with the inhibition of the phosphoinositide 3-kinase/AKT/ mammalian target of rapamycin signaling pathways. Consistently, we demonstrated that pamidronate and clodronate functionally abrogated both in vitro and in vivo tumor angiogenesis induced by IGF-1-stimulated MCF-7 cells. These findings have highlighted an important mechanism of the pharmacological action of bisphosphonates in the inhibition of tumor angiogenesis in breast cancer cells.

AB - Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, bisphosphonates exhibit antitumor activities, in vitro and in vivo, via several mechanisms, including antiangiogenesis. In this study, we investigated the potential molecular mechanisms underlying the antiangiogenic effect of non-nitrogen-containing and nitrogen-containing bisphosphonates, clodronate and pamidronate, respectively, in insulin-like growth factor (IGF)-1 responsive human breast cancer cells. We tested whether bisphosphonates had any effects on hypoxia-inducible factor (HIF)-1α/vascular endothelial growth factor (VEGF) axis that plays a pivotal role in tumor angiogenesis, and our results showed that both pamidronate and clodronate significantly suppressed IGF-1-induced HIF-1α protein accumulation and VEGF expression in MCF-7 cells. Mechanistically, we found that either pamidronate or clodronate did not affect mRNA expression of HIF-1α, but they apparently promoted the degradation of IGF-1-induced HIF-1α protein. Meanwhile, we found that the presence of pamidronate and clodronate led to a dose-dependent decease in the newly-synthesized HIF-1α protein induced by IGF-1 in breast cancer cells after proteasomal inhibition, thus, indirectly reflecting the inhibition of protein synthesis. In addition, our results indicated that the inhibitory effects of bisphosphonates on the HIF-1α/VEGF axis are associated with the inhibition of the phosphoinositide 3-kinase/AKT/ mammalian target of rapamycin signaling pathways. Consistently, we demonstrated that pamidronate and clodronate functionally abrogated both in vitro and in vivo tumor angiogenesis induced by IGF-1-stimulated MCF-7 cells. These findings have highlighted an important mechanism of the pharmacological action of bisphosphonates in the inhibition of tumor angiogenesis in breast cancer cells.

KW - Angiogenesis

KW - Bisphosphonates

KW - Breast cancer

KW - HIF-1α

KW - IGF-1

KW - PI-3K/Akt

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=73449089472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449089472&partnerID=8YFLogxK

U2 - 10.1002/ijc.24710

DO - 10.1002/ijc.24710

M3 - Article

C2 - 19569175

AN - SCOPUS:73449089472

VL - 126

SP - 90

EP - 103

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -